Introduction
The mucosal surfaces of the body comprise an enormous interface (estimated to 400 m 2 in the human adult intestine) that physically separates the interior of the body and the external environment. In contrast to the systemic compartment, which needs to remain sterile as the presence of a microorganism reflects a potentially life-threatening condition, mucosal surfaces are constantly challenged by a plethora of antigens of various nature and complexity.
A particular feature of the gastrointestinal tract is the presence of a very diverse and dense microbiota comprising as many as 10 14 bacterial cells, outnumbering the amount of cells composing the human body by a factor of up to 10. 1 In addition to peacefully co-exist with the host, an equilibrium referred to as commensalism, bacteria residing in the gut exhibit numerous protective and metabolic features essential to the filter function of the epithelial barrier lining mucosal surface. 2 In contrast to enteropathogens turning on multiple pro-inflammatory circuits that will lead to their elimination, commensal bacteria populating the gastrointestinal tract are not overtly inflammatory, and this results in graded or dampened responses appropriate to ensure their symbiotic persistence. 3 How commensal bacteria foster the development of the mucosal immune system, and in particular the stimulation of the biosynthesis of local SIgA, has been comprehensively reviewed lately. [4] [5] [6] SIgA is the most abundant antibody molecule on mucosal surfaces of humans and most other mammals. Production of IgA at mucosal surfaces contributes to host defense against intestinal pathogens 7, 8 and governs quantitative and qualitative control of commensal microbiota composition by the host. 9, 10 Globally, the presence of SIgA at mucosal surfaces warrants that proinflammatory processes are kept under control, a feature that is essential to preserve the integrity and functionality of the epithelial barrier. [11] [12] [13] While other antibody isotypes are rapidly degraded, intact SIgA molecules can be regularly demonstrated in samples from mucosal surfaces even in the presence of large numbers of microorganisms. SIgA abundantly found in mucosal secretions results from the association during transport across epithelial cells from J chain-containing polymeric IgA with secretory component (SC), the cleavage product of the polymeric Ig receptor (pIgR). 14 The stability of SIgA depends largely on SC, which masks potential proteolytic cleavage sites, 15, 16 ensuring preserved functionality in the enzymatically hostile environment that prevails on gut mucosal surfaces. In addition to its well documented role in pathogen neutralization and clearance, 7, 8, 10 SIgA is endowed with the capacity to selectively retro-transport bound antigens back into intestinal Peyer's patches across microfold (M) cells 17 via the Dectin-1 receptor expressed at their surface. 18 In the subepithelial dome (SED) region, SIgA-based immune complexes associate with dendritic cells (DCs), 19 resulting in the onset of immunomodulatory types of responses. 20 Seminal papers published by the team of John Cebra more than 2 decades ago have demonstrated that at weaning, up to 70% of commensal bacteria are coated with natural SIgA in the mouse gastrointestinal tract, and that this association is instrumental to the maintenance of bacterial homeostasis; 21, 22 the same holds true for pigs and calves. 23 Strikingly, interaction between commensals and SIgA is not only antigen-driven, 24 as natural polyreactive SIgA and Fab/Fc-independent, glycan-mediated binding are also likely to contribute substantially to this process. 25 The involvement of SIgA in the numerical control of the gut microbiota was further confirmed in germ-free or mono-associated mice. 26, 27 In IgA-deficient mice, systemic antibody responses against commensal species are increased, 28, 29 arguing for control of transepithelial dissemination by SIgA. The sum of these data provide evidence that mucosal SIgA is instrumental to contain and control the composition of commensal microbiota. 30 Provision of local SIgA appears thus to monitor the microbiota in some sort of a regulatory loop essential to ensure appropriate mucosal gut homeostasis. [31] [32] The review covers this specific topic.
SIgA-Driven Binding of Commensal Bacteria to Epithelial Cells is Mediated by the Transferrin
Receptor (CD71)
The importance of commensal bacteria in the maintenance of the integrity of intestinal epithelial cell (IEC) barrier and the control of the underlying immune mechanisms ensuring homeostasis is a fundamental process, whose multiple and complex features are not yet fully understood. [33] [34] [35] When considering the epithelial barrier function, in vitro exposure of reconstituted polarized Caco-2 epithelial cell monolayers to commensal strains either alone or coated with SIgA leads to a completely different pattern of a) cytokine/chemokine secretion, b) pIgR expression, and c) adhesion, indicating that the nature of the bacterium and the association with the antibody results in different sensing by the epithelial cells in the absence of any other partners. 36 While we speculated that commensal bacteria associated with SIgA would have a reduced effect on the reconstituted epithelial layer through mechanisms similar to immune exclusion, it happened that the presence of SIgA increased the bacterial anchoring at the apical surface of IECs. This event was accompanied by an increased phosphorylation of tight junction proteins sustaining cell-to-cell interaction. Increased production of thymic stromal lymphopoietin, a chemokine involved in maintaining a noninflammatory environment at mucosal surfaces, 37 was measured in the presence of SIgA. Furthermore, association of commensal bacteria with SIgA promoted pIgR production by IECs, leading to more receptor available for active SIgA transcytosis. 34 This phenomenon could account for the sustained SIgA secretion resulting from commensal colonization. 38 These characteristics argue for a contribution of SIgA in maintaining commensal bacteria at bay through a delicate balance combining appropriate neutralization and proper sensing by the IECs.
Several receptors for IgA have been identified on various cell populations including myeloid cells, DCs, T and B cells, hepatocytes and epithelial cells. 39 The presence of an IgA receptor different of pIgR and CD89 (FcalphaR1) on the human IEC line HT29 was first reported by Kitamura et al., 40 yet its precise identity was not elucidated. Studies on the transport of gliadin peptides from the lumen to the lamina propria led to the conclusion that CD71 (transferrin receptor) expressed by epithelial cells is also able to bind human polymeric and SIgA. 41 The possible role of apically exposed CD71 in the binding of SIgA was addressed in our laboratory by incubating fluorescently labeled mouse SIgA monoclonal antibody in the apical compartment of polarized Caco-2 epithelial cell monolayers mimicking the intestinal barrier. Interaction of the antibody (green) with CD71 (red) detected by a specific antiserum resulted in the appearance of yellow spots reflecting colocalization ( Fig. 1, top panels) . Under identical conditions, no interaction between CD71 and monomeric IgA could be observed, consistent with the lower affinity of this molecular form of the antibody. 42 The presence of functional CD71 at the apical surface of the Caco-2 cell monolayer was confirmed in colocalization experiments carried out upon addition of transferrin, the "natural" ligand of the receptor expressed by IECs 43 ( Fig. 1 , bottom panels). In addition, transcytosis via CD71 of human SIgA loaded with gliadin peptides was observed when using polarized Caco-2 cell monolayers. 44 The sum of these data is compatible with a role of CD71 in endocytosis/internalization into intracellular vesicles of SIgA-antigen complexes from the apical surface, with concomitant induction of specific immune responses, as this takes place for the transport of IgE-allergen complexes through CD23. 45 Further investigations are needed to unravel whether SIgA following this pathway can target lamina propria DCs, as this occurs for DCs in the SED region following retro-transport of SIgA across M cells in Peyer's patches. 17 SIgA-Driven Entry, and Subsequent Targeting to DCs, of Commensal Bacteria in Peyer's Patches
In addition to their interaction with enterocytes, commensal bacteria are known to be sensed by immune cells localized beyond the epithelial barrier, such as DCs residing in the lamina propria of the gut mucosa or, even more importantly, in organized lymphoid immune inductive sites such as Peyer's patches. 46 The fact that the majority of intestinal bacteria are naturally coated by SIgA molecules (see Introduction) together with the observation that SIgA per se or bound to antigens is targeted after transport via M cells to DCs in the SED region of Peyer's patches suggests a potential implication of the antibody in the process of sensing of commensal bacteria by this tissue. Such an hypothesis has been recently demonstrated in our laboratory by following via laser scanning confocal microscopy the dynamics of entry in Peyer's patches of fluorescently labeled bacteria injected into a mouse intestinal ligated loop. Association of the strains Lactobacillus Rhamnosus CGMCC 1.3724 36 (referred to as LPR in the text) or Bifidobacterium lactis CNCM 1.2618 36 (referred to as BL in the text) with non-specific mouse SIgA prior to injection into the intestinal loop allowed accelerated internalization of the bacteria within Peyer's patches, in particular in the SED region underlying the follicle-associated epithelium (Ref. 47 and Fig. 2A and B) .
Moreover, once in the tissue, the antibody-coated bacteria were found in close interaction with the CD11c C CD11b C subset of DCs prone to initiate local induction of IL-10 and TGF-b producing T cells involved in immune regulatory mechanisms. 48 Thus, SIgA appears as a vehicle facilitating the targeting and sensing of commensals by SED DCs ideally located to fulfill this function. This conclusion was further reinforced by the observation that bacteria injected into intestinal loops without initial association with SIgA were rapidly coated with endogenous luminal SIgA, resulting in subsequent transport across M cells followed by interaction with DCs in the SED region of Peyer's patches as well (Ref. 47 and Fig. 3) . Detection of SIgA-bacteria complexes with antibodies directed against the SC indicated that that bacteria were targeted to DCs in this particular form, in agreement with the capacity of SIgA to specifically interact with these cells. The time required for endogenous association to occur most likely explains the delay observed between bacteria delivered alone and those bound to SIgA prior to injection. In support of this, bacteria injected into intestinal loops of germ-free mice producing extremely reduced endogenous SIgA exhibit further limited entry into Peyer's patches as a function of time. 47 Interestingly, the dynamics of entry appeared to be different between the 2 investigated strains; while internalized BL administered into a ligated loop as such could be detected in close association with DCs in the SED region within 2 hours, LPR necessitated as much as 6 hours. Whether this is related to intrinsic bacterial strain properties, including capacity to bind to SIgA or luminal localization closer to the sampling site, or to host-related features as for instance the endogenous microbiota, is in need of further investigations. It can be postulated that the presence of more SIgA specific for Bifidobacteria than for Lactobacilli, although mice are more colonized by bacteria from the later genus, may impact on the way by which bacteria-SIgA complexes are formed and subsequently perceived by the host mucosal immune system. While the above-reported experiments support an intrinsic effect of the association of bacteria with non-specific SIgA via interactions with carbohydrate moieties, 49 we cannot exclude that antigenspecific recognition may be of an added value for the sensing process. In this respect, association between an antigen and its cognate specific SIgA triggers structural changes in the antibody, which in turn confers enhanced interaction with cognate receptors, 50 a feature which may explain the favored interaction of SIgA-coated commensals to M cells or DCs. Moreover, experiments done with mutant mice displaying limited diversity of the Ig repertoire due to a severe defect in somatic hypermutation, but having wild-type equivalent intestinal total IgA production, demonstrated that the incapacity to generate antigen-specific antibodies affected immune responsiveness to mucosal challenges as expected, but altered also the microbiota balance. 51 In conclusion, all these recent in vivo results strongly support the concept that association with SIgA not only facilitates selective entry of commensal bacteria across the gut epithelium, but may additionally be an important driver toward the optimal sensing of commensal bacteria in mucosal inductive sites such as PPs. These data provide partial clues as to the still puzzling issue of how SIgA contributes to the complex mechanisms of actively regulating mucosal immune homeostasis, in particular discrimination between noxious and resident microorganisms. 52 The question of the fine tuning of such SIgAdriven process in controlling commensal bacteria sensing by, and priming of, DCs remains to be further investigated.
Effect of SIgA on Commensal-BacteriaDriven Early Maturation of the Gut Immune System
While SIgA-driven commensal bacteria sampling and sensing appears as a constant ongoing process ensuring gut homeostasis, there are situations where its consequence is of outstanding importance. This is for example the case in the early life period; although neonates are exposed to a unique microbiome prior to birth, as mostly analyzed via 16S rRNA, 53, 54 progressive colonization by a developing microbiota ecosystem shortly after vaginal delivery requires control mechanisms to ensure appropriate symbiosis. 55 This colonization process and its interplay with the host is now commonly seen as a key factor to ensure proper post-natal maturation of the gut epithelium barrier and early programming of physiological processes, 2 features which positively influence health throughout life. [56] [57] [58] It is now generally accepted that induction/completion of immune maturation relies on the presence of newly established commensal intestinal microbes, and that such a process will lead to production of endogenous SIgA, which in turn shapes the composition of the microbiota. 59 This is illustrated by the virtually complete absence of IgA in neonates, as well as by its drastic reduction in germ-free animals, a status that returns to normality following colonization with a commensal microbiota. 60 The momentarily absence of endogenous SIgA production in newborns is compensated in mammals by provision of such antibodies through breast milk, whose concentration in humans ranges between 0.4 to 1.0 g/L. Breast milk SIgA may thus play an important role in early-life bacterial sensing by ensuring optimal microbiotadriven maturation and programming of the mucosal or systemic immune system.
To address this hypothesis, we investigated the impact of neonatal SIgA supplementation in an immune maturation's mouse model in which germ-free dams, whose breast milk is thus almost deprived of SIgA, were used to feed their pups exposed to mouse fecal bacteria to permit natural microbial colonization. Pups were daily supplemented during the pre-weaning period with either a saline solution (control for absence of SIgA), or the commensal bacteria BL known to promote immune maturation in humans, 61 or BL associated with non-specific murine SIgA, or the equivalent amount of the same SIgA alone. Monitoring of gut mucosal immune maturation through measurement of endogenous IgA production by ELISPOT measuring the number of IgA secreting cells in PPs and mesenteric lymph nodes revealed that association of BL with SIgA prior to administration was able to further potentiate the effect of BL on IgA production (Fig. 4) , possibly through driving of the access of the commensal to mucosal immune inductive sites, as discussed in the previous section. Interestingly, administration of SIgA alone also promoted immune maturation. This may result from the association of exogenous SIgA with the endogenous growing microbiota in the pups, resulting in enhanced sampling and sensing in Peyer's patches in comparison to the SIgA-deprived control protocol. Noteworthy, the fact that supplementation of only very small amounts of SIgA, such as 500 pg/day, provided an measurable effect on local IgA-producing cells further supports a key role of the antibody in the microbiota-host interaction taking place during the very particular and crucial early-life period. Noteworthy, the effect of the presence of SIgA were not only visible at weaning, i.e. at the end of the supplementation period (Fig. 4 , left panels), but was maintained for at least 6 weeks post-weaning (early adulthood, Fig. 4, right panels) . This supports the concept of a long-lasting impact on immune programming when priming is enhanced via the presence of SIgA during the very early life period. The recent observation that immunoregulation of DCs by SIgA is potent in inhibiting autoimmune responses in mouse models suggest that the antibody is important to establish healthy homeostasis and possibly to serve in disease prevention. 62 The importance of SIgA to ensure optimal immune maturation and to support long-term gut homeostasis was recently further supported in a totally different experimental model. Indeed, exploiting a mother foster approach with pIgR-sufficient and deficient mice, whose milk either contains or was devoid of SIgA, respectively, it was demonstrated that early exposure to maternal breast milk SIgA promoted intestinal epithelial barrier function. 63 In suckling neonates, this resulted in prevention of colonic damage caused by the epithelial-disrupting agent dextran sulfate sodium. More longterm effects including modulation of expression of intestinal epithelial cell genes associated with intestinal inflammatory diseases in humans and promotion of a healthy microbiota in adult mice were also observed. IgA-mediated control of the nature of microbiota partners during post-natal development has also been reported in a recent study, 64 suggesting that this mode of action of the antibody may find other examples in the future. 
Conclusion
The above-described studies shed light on the beneficial effects of surrogate natural SIgA (nonspecific monoclonal IgA) and maternal IgA in the mouse intestine, as illustrated by epithelial cell programming, maintenance of tissue homeostasis or the regulation of immune maturation. The strict quantitative and qualitative contribution of commensal-specific affinity-matured SIgA in such a process remains to be confirmed through the use of purified antibody. It appears a sound speculation to anticipate that the key role of natural SIgA of low affinity would be to support SIgA-mediated sensing of commensals to drive optimal immune priming by the nascent microbiota. Such an early event would in turn foster initial gut homeostasis early in life, while affinity-matured antigen specific SIgA would be involved in the protection against less frequently encountered pathogens. 65 The dichotomy in the "aggressiveness" of the mucosal humoral response may represent a mechanism ensuring the symbiotic Figure 4 . Presence of SIgA during the pre-weaning period promotes early-life immune maturation. Mouse pups from germ-free dams were daily supplemented for the last 14 d of the suckling period with either a saline solution (PBS, control for absence of SIgA), 10 4 CFU of the commensal bacteria BL known to promote immune maturation in humans, 10 4 CFU of BL associated with 500 pg of non-specific murine SIgA monoclonal antibody 28 , or the equivalent amount of the same SIgA alone. Germ-free dams have an almost completely SIgA-deprived milk. Concomitantly to supplementation, pups were exposed to conventional mouse fecal bacteria to induce natural microbial colonization. Monitoring of mucosal immune maturation was assessed through quantification of the number IgA secreting cells in Peyer's patches (PPs, top panels) and mesenteric lymph nodes (MLNs, bottom panels), as measured by the ELISPOT technique (median § SEM). IgA production was assessed at the end of the supplementation period (weaning, day 21 of age, left panels) and 6 weeks later (early adulthood, day 63 of age, right panels). Statistical significance (Wilcoxon test) is indicated by the letters: a D P < 0.001 vs. PBS control; b D P 0.002 vs. BL alone; c D P < 0.001 vs. SIgA alone. n D 10 to 11 pups per experimental group for each organ and time point investigated.
relationship between the host and its microbiota, as opposed to blocking and elimination required to fight invasive bacteria.
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